BusinessEli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug MarketBy Riza DagocDec 24, 2025, 3:42 AM UTC
BusinessNovo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight LossBy Riza DagocDec 23, 2025, 1:57 AM UTC
BusinessAstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer StudyBy Riza DagocDec 22, 2025, 7:39 AM UTC
GovernanceFDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot ProgramBy Riza DagocDec 20, 2025, 1:55 AM UTC
BusinessSanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung DiseaseBy Riza DagocDec 17, 2025, 7:02 AM UTC
GovernanceFDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety DebateBy Riza DagocDec 16, 2025, 4:35 AM UTC
BusinessCalifornia Jury Awards $40 Million in Johnson & Johnson Talc Cancer LawsuitBy Riza DagocDec 15, 2025, 2:19 AM UTC
BusinessChina to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025By Riza DagocDec 8, 2025, 3:00 AM UTC
